Veracyte (VCYT) Receivables (2016 - 2025)
Historic Receivables for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $47.8 million.
- Veracyte's Receivables fell 201.0% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year decrease of 201.0%. This contributed to the annual value of $46.5 million for FY2024, which is 1522.36% up from last year.
- Per Veracyte's latest filing, its Receivables stood at $47.8 million for Q3 2025, which was down 201.0% from $50.8 million recorded in Q2 2025.
- In the past 5 years, Veracyte's Receivables registered a high of $53.8 million during Q1 2025, and its lowest value of $27.9 million during Q1 2021.
- Its 5-year average for Receivables is $43.2 million, with a median of $42.5 million in 2022.
- In the last 5 years, Veracyte's Receivables soared by 12865.17% in 2021 and then crashed by 827.56% in 2023.
- Quarter analysis of 5 years shows Veracyte's Receivables stood at $41.5 million in 2021, then rose by 6.17% to $44.0 million in 2022, then decreased by 8.28% to $40.4 million in 2023, then increased by 15.22% to $46.5 million in 2024, then grew by 2.8% to $47.8 million in 2025.
- Its last three reported values are $47.8 million in Q3 2025, $50.8 million for Q2 2025, and $53.8 million during Q1 2025.